The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer.
about
Resveratrol: A Focus on Several Neurodegenerative DiseasesTumor suppressor p53 and its gain-of-function mutants in cancerP53 mutations in colorectal cancer - molecular pathogenesis and pharmacological reactivationDrug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms.Zinc oxide nanoparticles-induced epigenetic change and G2/M arrest are associated with apoptosis in human epidermal keratinocytesBenzo[a]pyrene (BP) DNA adduct formation in DNA repair-deficient p53 haploinsufficient [Xpa(-/-)p53(+/-)] and wild-type mice fed BP and BP plus chlorophyllin for 28 daysp53 transactivation and the impact of mutations, cofactors and small molecules using a simplified yeast-based screening systemIdentification of 5-Iodotubercidin as a genotoxic drug with anti-cancer potentialMithramycin exerts an anti-myeloma effect and displays anti-angiogenic effects through up-regulation of anti-angiogenic factorsThe dichotomy of p53 regulation by noncoding RNAs.Matrine reduces the proliferation of A549 cells via the p53/p21/PCNA/eIF4E signaling pathway.Design and synthesis of novel N()-substituted thiosemicarbazones bearing a pyrrole unit as potential anticancer agents.TESTIN suppresses tumor growth and invasion via manipulating cell cycle progression in endometrial carcinoma.Expression of histone deacetylases in diffuse large B-cell lymphoma and its clinical significanceChemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications.Topical application of ochratoxin A causes DNA damage and tumor initiation in mouse skin.A novel in vitro model for studying quiescence and activation of primary isolated human myoblasts.Harmine activates intrinsic and extrinsic pathways of apoptosis in B16F-10 melanomaRapid and Sensitive Detection of p53 Based on DNA-Protein Binding Interactions Using Silver Nanoparticle Films and Microwave Heating.Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122.The functional role of long non-coding RNA in human carcinomas.SPATA12 and its possible role in DNA damage induced by ultraviolet-C.Overexpression of WRAP53 is associated with development and progression of esophageal squamous cell carcinomaDeletion of Rb accelerates pancreatic carcinogenesis by oncogenic Kras and impairs senescence in premalignant lesions.p53 in stem cellsTegillarca granosa extract Haishengsu induces apoptosis in human hepatocellular carcinoma cell line BEL-7402 via Fas-signaling pathways.TESTIN was commonly hypermethylated and involved in the epithelial-mesenchymal transition of endometrial cancer.TP53 transcription factor for the NEDD9/HEF1/Cas-L gene: potential targets in Non-Small Cell Lung Cancer treatment.Down-regulation of STAT3 expression using vector-based RNA interference promotes apoptosis in Hepatocarcinoma cells.Time and Concentration-Dependent Therapeutic Potential of Silver Nanoparticles in Cervical Carcinoma Cells.Transcriptional analysis of immune-related gene expression in p53-deficient mice with increased susceptibility to influenza A virus infectionNutrient/serum starvation derived TRIP-Br3 down-regulation accelerates apoptosis by destabilizing XIAP.Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species.In Vitro Therapeutic Potential of Tio2 Nanoparticles Against Human Cervical Carcinoma Cells.Differential Sensitivity of Madin-darby Canine Kidney (MDCK) Cells to Epinephrine.Epothilones Suppress Neointimal Thickening in the Rat Carotid Balloon-Injury Model by Inducing Vascular Smooth Muscle Cell Apoptosis through p53-Dependent Signaling Pathway.N-(phosphonacetyl)-L-aspartate induces TAp73-dependent apoptosis by modulating multiple Bcl-2 proteins: potential for cancer therapy.Enhancement of ionizing radiation response by histamine in vitro and in vivo in human breast cancer.Association of RNF43 with cell cycle proteins involved in p53 pathway.Phosphorylation of TPP1 regulates cell cycle-dependent telomerase recruitment
P2860
Q26800952-C198E327-9471-451F-A04F-538651E3DD7BQ27000754-8D297170-D2A0-407C-8442-D080F4408970Q27021759-58019935-8C09-4620-9E44-191550EC538EQ27692033-6BD35DD1-C4B9-4364-92C9-BC83F0686282Q28386787-BCB30F86-AECF-4280-89E5-A3CCFC250A3CQ28391046-B695E0BC-AE6F-43D6-B055-85575CE3B3CBQ28478414-D664E8D9-2E6B-4447-B384-10A187AED07CQ28487720-20CE67D5-60C8-496E-835E-11F59F47689FQ28487743-40F4801A-43B0-4427-A6BA-B5451DF8D740Q33668469-7F0485F1-076A-44D2-893B-6B045C649100Q33672267-B1BECD45-7B08-42AA-802A-16F40EF04C62Q33751332-F0FEACBA-3BD2-4F0A-ACB5-5C9E304875D3Q33793936-A783C4C3-7459-45E0-BE44-1FB3523352D9Q33970364-4D1925F4-3983-4FB8-B371-728C91B00F56Q34094748-6ED0069A-3A41-45DA-8837-76A3FDBF3A04Q34448145-4B2E7524-3628-445B-BD93-94A777931785Q34745089-93370022-3B54-4BDE-AF93-BB2D5D16F599Q34790727-D79D18FD-A41A-4F7D-B616-AEF218A7BF23Q34817342-98D434EC-B425-48FE-8276-46862B9B82D6Q34979073-8A0D0D1B-11F6-4FE8-9FA4-9679FD7FEA54Q34995156-7CD79676-4B30-4A5A-8C81-F6C84EECA4B1Q35036196-14699CCD-2E82-4CF7-A1A4-E2E1C5DED999Q35120227-564CAC01-8EDE-4A97-BACC-C13873D813D3Q35186531-C09A5AEE-4349-4744-8875-9CFA6E1D3E63Q35228392-ED552C1A-7D92-4995-B8C0-DA47C7E029D8Q35278136-4C5A32F1-8117-4C34-A072-89BE73F8F94FQ35568351-8752581F-FF10-4075-8A09-792FEC9CDB95Q35646576-9BD9B629-38CC-439F-995F-BD060318F9A4Q35680848-78886881-F64D-4240-89BD-441449161850Q35747004-C7992AA3-C053-482F-A076-82F3C0C3311EQ35748249-383C85F2-D61C-4C01-A26C-D7AA9D064B0CQ35781341-610A9DCE-22C1-4400-B509-A9FD19A29397Q35787510-5197FD46-ECCE-489C-8F13-1DF816D0E288Q35828133-CD9AEC68-DA0A-4DBA-8A92-9DEF6E8FDEBDQ35996550-4389B6D2-C27F-49C9-A15F-BDFB37678E47Q36027735-01763181-1AC8-4F7F-842C-D322B454C8F8Q36055168-55D2A397-A2EA-4757-8CDA-2D1BEA0EB1C6Q36213171-17667B45-BAB6-40E3-AFA8-F2562B79B212Q36464762-AE082C3B-16C8-4D12-8D20-918B6724B3A6Q36747492-18D4CF7D-9441-468D-A28B-9A2640D1C295
P2860
The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The p53 tumor suppressor: a ma ...... therapeutic target in cancer.
@en
The p53 tumor suppressor: a ma ...... therapeutic target in cancer.
@nl
type
label
The p53 tumor suppressor: a ma ...... therapeutic target in cancer.
@en
The p53 tumor suppressor: a ma ...... therapeutic target in cancer.
@nl
prefLabel
The p53 tumor suppressor: a ma ...... therapeutic target in cancer.
@en
The p53 tumor suppressor: a ma ...... therapeutic target in cancer.
@nl
P2093
P1476
The p53 tumor suppressor: a ma ...... therapeutic target in cancer.
@en
P2093
Klas G Wiman
Marianne Farnebo
Vladimir J N Bykov
P356
10.1016/J.BBRC.2010.02.152
P407
P577
2010-05-01T00:00:00Z